Digital Pathology Technology Innovations and Growth Opportunities

Digital Pathology Technology Innovations and Growth Opportunities

Disruptive technologies like AI-based image analysis algorithms are boosting diagnostics and drug development research

The digital pathology industry is witnessing steadily increasing competitive intensity, with the entry of several start-ups putting market players under pressure to create unique, disruptive products. While digital pathology includes slide digitalization, image analysis algorithms, and image storage and management solutions, this report focuses on slide digitization technologies and image analysis algorithms, which have the highest innovation index. The current generation of digital pathology uses whole-tissue slide digitalization and intelligent image analysis to address the challenges of conventional histopathology practices. Whole slide scanning systems eliminate the risk of slide damage as well as the need for time-consuming slide transportation to the pathologist and storage involving physical space. Advanced AI-based image analysis algorithms address the limited image characterization capabilities of conventional computational pathology. The scarcity of pathologists and the limited analytical capabilities of conventional histopathology also drive the adoption of digital pathology solutions. The study charts the evolution of digital pathology technology and identifies its applications in research and diagnostic pathology. It also examines the impact of these developments on the needs of the industry.

Key Questions Addressed by This Study:

1. What is digital pathology, and what are the industry needs for the technology? What are the applications?
2. What are the factors driving and restraining the growth of the digital pathology industry? What are the regional trends?
3. What are the technology segments under digital pathology? Who are the participants in the slide digitalization and image analysis algorithms segments? What are the technologies employed, features of the solutions, target applications, and commercial readiness levels?
4. Who are the key adopters of the technology, and what has been the impact of the adoption?
5. What is the enterprise pathology solution, and who are the providers?
6. What are the funding, mergers and acquisitions (M&A), and patent filing trends in the industry?
7. What are the growth opportunities emerging from the changes in the digital pathology industry for market players and stakeholders to leverage?